Metformin hydrochloride is widely used to treat diabetes mellitus. This review presents its physical and chemical properties and discusses methods of analysis that allow a quality assessment of metformin hydrochloride both as an individual drug and in combination with other antidiabetic medicines. The most widely used method is HPLC combined with spectrophotometry and other methods of analysis. The review is based on data from foreign and domestic articles and on our research results.
Similar content being viewed by others
References
Vidal 2019. Vidal’s Handbook. Pharmaceuticals in Russia [in Russian], GEOTAR, Moscow (2019).
Yu. V. Sul’skaya, Ratsion. Farmakoter., No. 3 (48), 52 – 63 (2018).
Regulatory Document LP-004568-061217. Metformin MS. Metformin. Film-coated Tablets, 500 mg, 850 mg and 1000 mg. Replaces No. 1 LP-004568-150618. Replaces No. 2. LP004568-160120. AO Medisorb.
The History of Metformin: 2007 – 50 Years of Use, Ozhirenie Metab., No. 3 58 (2007).
State Pharmacopoeia of the Russian Federation. XIVth Ed., in 4 Vols., Vol. 3, Metformin Hydrochloride, PM.2.1.0137.18, p. 4391.
European Pharmacopoeia (ver. 8.0). Metformin Hydrochloride, European Pharmacopoeia Identification Test C using Silica Gel G TLC Plates.
United State Pharmacopeia and National Formulary (USP34-NF29). Rockville, MD: US Pharmacopeia 2011, pp. 3442 – 3443.
British Pharmacopoeia. London. The Stationery Office / Medicines and Healthcare Products Regulatory Agency (MHRA), London (2011), p. 2983.
Drug Master File open part for Metformin Hydrochloride produced by Weifa AS, Ver. 2012 – 03.
Development and validation of analytical methods for determination of some anti-diabetic drugs in bulk and their pharmaceutical dosage forms, A. H. Patwari, 2014, Chap. 2.
PubChem Database of Chemical Compounds and Mixtures; https: // pubchem.ncbi.nlm.nih.gov / compound / 6918537#section=Chemical-and-Physical-Properties (accessed Nov. 10,2020).
K. R. Patil, T. A. Deshmukh, and V. R. Patil, World J. Pharm. Pharm. Sci., 4(09), 1151 – 1162 (2015).
N. K. Abood, D. Mahmood, and A. M. Abass, Int. J. Res. Eng. Innovation, 4(2), 91 – 95 (2020); https://doi.org/10.36037/IJREI.2020.4203.
M. T. da Trindade, A. C. Kogawa, and H. R. N. Salgado, Crit. Rev. Anal. Chem., 48(1), 66 – 72 (2018).
E. Prugnard and M. Noel, in: Oral Antidiabetics, J. Kuhlmann (ed.), Walter Puls, (1996), pp. 287 – 304. doi: 10.1007/978-3-662-09127-2.
S. Mondal, R. N. Samajdar, S. Mukherjee, et al., J. Phys. Chem. B, 122(8), 2227 – 2242 (2018).
B. Hernandez, F. Pfluger, S. G. Kruglik, et al., J. Pharm. Biomed. Anal., 114, 42 – 48 (2015).
S. Naveed, H. Rehman, F. Qamar, et al., Int. J. Pharm. Sci. Res., 5(10), 714 – 717, (2014).
F. Tache and M. Albu, Rev. Roum. Chim., 52(6), 603 – 609 (2007).
G. Kiaczkow and E. Anuszewska, Acta Pol. Pharm., 67(6), 593 – 598 (2010).
T. Sudha, V. Krishna, and V. R. Kumar, Res. Rev.: J. Pharm. Anal., 3(1), 27 – 33, (2014).
E. R. Sartori, W. T. Suarez, et al., Quím. Nova [online], 32(7), 1947 – 1950 (2009).
J. Pyzowski, M. Lenartowicz, A. W. Sobanska, et al., Zh. Prikl. Spektrosk., 84(4), 671 (2017).
H. Ibrahim and M. S. Kamel, Science Direct Working Paper (2002). No. S1574 – 0331(04)70870-X.
F. Farouk, B. A. Moussa, and H. M. El-Said Azzazy, Spectroscopy, 26(4 – 5), 297 – 309 (2011).
S. M. Eid, S. S. Soliman, M. R. Elghobashy, et al., Vib. Spectrosc., 106, 102995 (2020).
A. Gumieniczek, A. Berecka-Rycerz, T. Mroczek, et al., Molecules, 24(24), 4430 (2019).
R. I. El-Bagary, E. F. Elkady, and B. M. Ayoub, Int. J. Biomed. Sci., 9(1) 41 – 47 (2013).
M. F. Abdel-Ghany, O. Abdel-Aziz, M. F. Ayad, et al., Spectrochim. Acta, Part A, 125, 175 – 182 (2014). doi: https://doi.org/10.1016/j.saa.2014.01.055.
G. Mubeen and K. Noor, Indian J. Pharm. Sci., 1, 100 – 102 (2009).
G. Mubeen, K. Noor, V. M. N. Al-Ameen, et al., Int. J. ChemTech Res., 2(2), 1186 – 1187 (2010).
A. T. Barden, B. L. Piccoli, N. M. Volpato, et al., Drug Anal. Res., 2(1), 46 – 53 (2018).
M. A. Mohammad, E. F. Elkady, and M. A. Foaud, Eur. J. Chem., 3(2), 152 – 155 (2012).
N. S. Abdelwahab, M. M. Abdelrahman, J. M. Boshra, et al., J. Planar Chromatogr., 32(4), 309 – 316, (2019).
F. Al-Rimawi, Talanta, 79(5), 1368 – 1371, (2009).
HPLC Analysis of Metformin and Related Impurities Cyanoguanidine and Melamine on SeQuant(R) ZIC-HILIC; https://www.sigmaaldrich.com/technical-documents/articles/analytical-applications / hplc / hplc-analysis-of-metformin-andrelated-impurities-cyanoguanidine-and-melamine-g1007265.html#newMaterials ().
S. B. Baokar, S. V. Mulgund, and N. S. Ranpise, Res. J. Pharm. Dosage Forms Technol., 5(2), 95 – 98 (2013).
S. Lohit. Ch, S. Pattanayak, and T. R. Rao, Am. J. PharmTech Res., 4(5), 138 – 145, (2014).
N. Satheeshkumar M. Pradeepkumar S. Shanthikumar, et al., Drug Res., 64(3), 124 – 129 (2014).
H. A. Merey, N. K. Ramadan, S. S. Diab, and A. A. Moustafa, Bull. Fac. Pharm. (Cairo Univ.), 55(2), 311 – 317 (2017).
R. G. Mansurova and N. V. Z. A. Gazizova, in: Current Issues of Judicial Medicine and Rights, Kazan (2010), No. 1, 282 pp.
R. I. El-Bagary, E. F. Elkady, and B. M. Ayoub, Int. J. Biomed. Sci., 7(3), 201 – 208 (2011).
A. Gedawy, H. Al-Salami, and C. R. Dass, J. Food Drug Anal., 27, 315 – 322 (2019).
K. S. Lakshmi, T. Rajesh, and S. Sharma, Int. J. Pharm. Pharm. Sci., 1(2), 162 (2009).
M. S. Arayne, N. Sultana, and M. H. Zuberi, Pak. J. Pharm. Sci., 19(3) 231 – 235 (2006).
I. O. A. Reid, Pharma Innovation, 6(5), 157 – 160 (2017).
S. A. Kumar, M. Debnath, and J. V. L. N. Seshagiri Rao, Pharm. Sin., 4(4), 47 – 61 (2013).
C. P. Uber, F. Lada, D. Pontes, et al., Int. J. Pharm. Pharm. Sci., 6(11), 203 – 207 (2014).
R. Q. Gabr, R. S. Padwal, and D. R. Brocks, J. Pharm. Pharm. Sci., 13(4), 486 – 494 (2010).
Y.-J. Kang, H.-C. Jeong, T.-E. Kim, et al., Molecules, 25, 4625 (2020).
I. I. Hamdan, A. K. Bani Jaber, and A. M. Abushoffa, J. Pharm. Biomed. Anal., 53(5), 15 (2010).
J. Z. Song, H. F. Chen, S. J. Tian, et al., J. Chromatogr. B. Biomed. Sci. Appl., 708(1 – 2), 277 – 283, (1998).
H. Maher, A. E. Abdelrahman, N. Alzoman, et al., J. Liq. Chromatogr. Relat. Technol., 42(4), 1 – 11 (2019).
E. Ucakturk, Anal. Methods, 5(18), 4723 – 4730 (2013).
S. S. Havele and S. R. Dhaneshwar, J. Liq. Chromatogr. Relat. Technol., 34(12), 966 – 980 (2011). DOI: https://doi.org/10.1080/10826076.2011.557465.
E. El-Kimary, D. Hamdy, S. S. Mourad, et al., J. Chromatogr. Sci., 54(1), 79 – 87 (2015).
C. Goedecke, I. Fettig, C. Piechotta, et al., Anal. Methods, 9(10), 1580 – 1584, (2017).
K. Amal, S. A. Nessreen, E. A. Abdelaleem, et al., J. Pharm. Pharm. Sci., 5(3), 1 – 8 (2018).
M. A. Mohamed, A. K. Attia, and W. Salem, Acta Chim. Slov., 62(3), 588 – 594, (2015).
M. B. Gholivand and L. Mohammadi-Behzad, Anal. Biochem., 438(1), 53 – 60 (2013). doi: https://doi.org/10.1016/j.ab.2013.03.019.
K. N. Toraev, L. V. Evseeva, and S. N. Gubar’, Upr. Ekon. Zabezpech. Yakosti Farm., 6(44), 18 – 24 (2015).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 55, No. 10, pp. 59 – 64, October, 2021.
Rights and permissions
About this article
Cite this article
Polyakova, E.B., Sabirzyanov, D.R., Prozorova, N.A. et al. Physicochemical Properties and Methods for the Determination of Metformin Hydrochloride (A Review). Pharm Chem J 55, 1119–1125 (2022). https://doi.org/10.1007/s11094-021-02546-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-021-02546-2